TrialCancer prevention research (Philadelphia, Pa.)2026
The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.
Leigha Senter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.